rs16895517

Variant summary

Our verdict is Benign. The variant received -20 ACMG points: 0P and 20B. BP4_StrongBP6_Very_StrongBA1

The NM_001142800.2(EYS):​c.5617C>G​(p.Leu1873Val) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.129 in 1,547,842 control chromosomes in the GnomAD database, including 13,774 homozygotes. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. L1873R) has been classified as Uncertain significance.

Frequency

Genomes: 𝑓 0.098 ( 913 hom., cov: 32)
Exomes 𝑓: 0.13 ( 12861 hom. )

Consequence

EYS
NM_001142800.2 missense

Scores

1
16

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:8

Conservation

PhyloP100: -0.00600

Publications

15 publications found
Variant links:
Genes affected
EYS (HGNC:21555): (eyes shut homolog) The product of this gene contains multiple epidermal growth factor (EGF)-like and LamG domains. The protein is expressed in the photoreceptor layer of the retina, and the gene is mutated in autosomal recessive retinitis pigmentosa. Multiple transcript variants encoding different isoforms have been found for this gene. [provided by RefSeq, Dec 2008]
EYS Gene-Disease associations (from GenCC):
  • EYS-related retinopathy
    Inheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
  • retinitis pigmentosa
    Inheritance: AR, AD Classification: DEFINITIVE, SUPPORTIVE Submitted by: G2P, Orphanet
  • retinitis pigmentosa 25
    Inheritance: AR Classification: DEFINITIVE, STRONG Submitted by: Ambry Genetics, Labcorp Genetics (formerly Invitae), Laboratory for Molecular Medicine

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -20 ACMG points.

BP4
Computational evidence support a benign effect (MetaRNN=0.0017262399).
BP6
Variant 6-64590250-G-C is Benign according to our data. Variant chr6-64590250-G-C is described in ClinVar as Benign. ClinVar VariationId is 93618.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BA1
GnomAd4 highest subpopulation (EAS) allele frequency at 95% confidence interval = 0.156 is higher than 0.05.

Variant Effect in Transcripts

ACMG analysis was done for transcript: NM_001142800.2. You can select a different transcript below to see updated ACMG assignments.

RefSeq Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYS
NM_001142800.2
MANE Select
c.5617C>Gp.Leu1873Val
missense
Exon 26 of 43NP_001136272.1
EYS
NM_001292009.2
c.5617C>Gp.Leu1873Val
missense
Exon 26 of 44NP_001278938.1

Ensembl Transcripts

Selected
GeneTranscriptTagsHGVScHGVSpEffectExon RankProteinUniProt
EYS
ENST00000503581.6
TSL:5 MANE Select
c.5617C>Gp.Leu1873Val
missense
Exon 26 of 43ENSP00000424243.1
EYS
ENST00000370621.7
TSL:1
c.5617C>Gp.Leu1873Val
missense
Exon 26 of 44ENSP00000359655.3

Frequencies

GnomAD3 genomes
AF:
0.0985
AC:
14972
AN:
152066
Hom.:
916
Cov.:
32
show subpopulations
Gnomad AFR
AF:
0.0280
Gnomad AMI
AF:
0.105
Gnomad AMR
AF:
0.123
Gnomad ASJ
AF:
0.0723
Gnomad EAS
AF:
0.166
Gnomad SAS
AF:
0.112
Gnomad FIN
AF:
0.0736
Gnomad MID
AF:
0.0696
Gnomad NFE
AF:
0.135
Gnomad OTH
AF:
0.0967
GnomAD2 exomes
AF:
0.118
AC:
17874
AN:
151430
AF XY:
0.119
show subpopulations
Gnomad AFR exome
AF:
0.0222
Gnomad AMR exome
AF:
0.135
Gnomad ASJ exome
AF:
0.0822
Gnomad EAS exome
AF:
0.175
Gnomad FIN exome
AF:
0.0820
Gnomad NFE exome
AF:
0.132
Gnomad OTH exome
AF:
0.118
GnomAD4 exome
AF:
0.132
AC:
184174
AN:
1395658
Hom.:
12861
Cov.:
33
AF XY:
0.132
AC XY:
90609
AN XY:
688162
show subpopulations
African (AFR)
AF:
0.0200
AC:
628
AN:
31420
American (AMR)
AF:
0.135
AC:
4762
AN:
35354
Ashkenazi Jewish (ASJ)
AF:
0.0797
AC:
1988
AN:
24942
East Asian (EAS)
AF:
0.145
AC:
5163
AN:
35696
South Asian (SAS)
AF:
0.104
AC:
8224
AN:
78852
European-Finnish (FIN)
AF:
0.0808
AC:
3974
AN:
49188
Middle Eastern (MID)
AF:
0.0573
AC:
325
AN:
5670
European-Non Finnish (NFE)
AF:
0.141
AC:
151985
AN:
1076736
Other (OTH)
AF:
0.123
AC:
7125
AN:
57800
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.473
Heterozygous variant carriers
0
7752
15505
23257
31010
38762
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
5566
11132
16698
22264
27830
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.0983
AC:
14966
AN:
152184
Hom.:
913
Cov.:
32
AF XY:
0.0967
AC XY:
7190
AN XY:
74390
show subpopulations
African (AFR)
AF:
0.0279
AC:
1159
AN:
41552
American (AMR)
AF:
0.123
AC:
1874
AN:
15250
Ashkenazi Jewish (ASJ)
AF:
0.0723
AC:
251
AN:
3470
East Asian (EAS)
AF:
0.166
AC:
855
AN:
5160
South Asian (SAS)
AF:
0.112
AC:
543
AN:
4828
European-Finnish (FIN)
AF:
0.0736
AC:
781
AN:
10612
Middle Eastern (MID)
AF:
0.0680
AC:
20
AN:
294
European-Non Finnish (NFE)
AF:
0.135
AC:
9185
AN:
67998
Other (OTH)
AF:
0.0957
AC:
202
AN:
2110
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.502
Heterozygous variant carriers
0
694
1389
2083
2778
3472
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
170
340
510
680
850
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.126
Hom.:
1015
Bravo
AF:
0.102
TwinsUK
AF:
0.135
AC:
499
ALSPAC
AF:
0.128
AC:
494
ESP6500AA
AF:
0.0282
AC:
39
ESP6500EA
AF:
0.140
AC:
445
ExAC
AF:
0.0948
AC:
2078
Asia WGS
AF:
0.121
AC:
421
AN:
3478

ClinVar

Significance: Benign
Submissions summary: Benign:8
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:4
Aug 11, 2011
GeneDx
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease.

Sep 25, 2013
Eurofins Ntd Llc (ga)
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Joint Genome Diagnostic Labs from Nijmegen and Maastricht, Radboudumc and MUMC+
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Clinical Genetics DNA and cytogenetics Diagnostics Lab, Erasmus MC, Erasmus Medical Center
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

Retinitis pigmentosa Benign:2
Jan 12, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease.

Sep 16, 2020
Natera, Inc.
Significance:Benign
Review Status:no assertion criteria provided
Collection Method:clinical testing

not provided Benign:1
Feb 03, 2025
Labcorp Genetics (formerly Invitae), Labcorp
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Retinal dystrophy Benign:1
Oct 01, 2023
Dept Of Ophthalmology, Nagoya University
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:research

Computational scores

Source: dbNSFP v4.9

Name
Calibrated prediction
Score
Prediction
AlphaMissense
Benign
0.074
BayesDel_addAF
Benign
-0.68
T
BayesDel_noAF
Benign
-0.60
CADD
Benign
1.1
DANN
Benign
0.24
DEOGEN2
Benign
0.035
T
Eigen
Benign
-1.3
Eigen_PC
Benign
-1.2
FATHMM_MKL
Benign
0.047
N
LIST_S2
Benign
0.32
T
MetaRNN
Benign
0.0017
T
MetaSVM
Benign
-1.1
T
MutationAssessor
Benign
0.0
N
PhyloP100
-0.0060
PrimateAI
Benign
0.19
T
PROVEAN
Benign
-0.10
N
REVEL
Benign
0.088
Sift
Benign
0.61
T
Sift4G
Pathogenic
0.0
D
Polyphen
0.0010
B
Vest4
0.021
MPC
0.0097
ClinPred
0.00026
T
GERP RS
2.0
Varity_R
0.040
gMVP
0.0094
Mutation Taster
=98/2
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs16895517; hg19: chr6-65300143; COSMIC: COSV107369956; COSMIC: COSV107369956; API